NDC 59148-047-90 - BUSULFEX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59148-047
- Requested NDC
- 59148-047-90
- Package NDCs from labels
- 59148-047-90, 59148-047-91
- Manufacturer
- Otsuka America Pharmaceutical, Inc. | Galbraith Laboratories, Inc. | Eurofins Lancaster Laboratories, Inc | Avista Pharma Solutions, Inc. | Alcami Missouri Corporation | Sharp Corporation | Baxter Oncology GmbH | Mayne Pharma Inc.
- Effective date
- 2020-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BUSULFEX | Otsuka America Pharmaceutical, Inc. | Galbraith Laboratories, Inc. | Eurofins Lancaster Laboratories, Inc | Avista Pharma Solutions, Inc. | Alcami Missouri Corporation | Sharp Corporation | Baxter Oncology GmbH | Mayne Pharma Inc. | 2020-04-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59148-047-90 | ML - Milliliter | 59148-047 | 56c4854c-1ad4-4bc2-b12d-fc35d70be1d7 | 1 | 2015-10-02 |
| 59148-047-91 | ML - Milliliter | 59148-047 | e5ff690c-2c36-430a-99bf-b43bdc34b863 | 1 | 2015-03-03 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Systane Lubricant | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 15bc06ec-f3dc-3180-ca1a-106769a770ea | 2023-12-15 | Warnings | B697894SGQ |
| Systane ULTRA | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | a5c1c194-3db5-4f18-9cd1-97f7f84c3cff | 2023-12-15 | Warnings | B697894SGQ |
| GenTeal Tears Gel Drops | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 84388a75-9d11-48ce-bf5a-88f0580d2d03 | 2023-12-14 | Warnings | B697894SGQ |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | B697894SGQ |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | B697894SGQ |
| Anubis Barcelona Protective Line | ETHYLHEXYL METHOXYCINNAMATE, BUTYL METHOXYDIBENZOYLMETHANE, ETHYLHEXYL SALICYLATE, OCTOCRYLENE | ANUBIS COSMETICS SL | ec83846f-11c0-8f59-e053-2995a90ab9d2 | 2023-09-01 | Warnings | B697894SGQ |
| Busulfan | BUSULFAN | Pharmascience Inc. | d0fe44f9-7747-4909-b927-3b24aa6e7e09 | 2022-05-18 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| BUSULFAN | BUSULFAN | Hospira, Inc. | b9c7f0dc-988d-466e-8031-400ec4f60f21 | 2021-08-09 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Meitheal Pharmaceuticals Inc. | dc384f16-4e25-458e-874c-553f81c6d8c9 | 2021-06-14 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Meitheal Pharmaceuticals Inc. | 6e68ab21-19bd-4b7e-b8d0-bf284d5af183 | 2021-06-14 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| Busulfan | BUSULFAN | Amneal Pharmaceuticals LLC | ac9448da-37ad-4609-9aef-eedf8be0f69c | 2020-09-23 | Boxed warning, Warnings, Adverse reactions | G1LN9045DK |
| d7b694d9-44f8-4c35-99ed-c8cf320e7ac5 | e03a2579-fb59-4c77-b487-0a72cb8cd76e | 2020-04-16 | Boxed warning, Warnings, Adverse reactions | d7b694d9-44f8-4c35-99ed-c8cf320e7ac5 e03a2579-fb59-4c77-b487-0a72cb8cd76e |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.